BusinessColibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI SystemBy Nasdaq OMXMay 4, 2018, 3:09 PM UTC
BusinessNSAV ANNOUNCES CORRECTIVE PRESS RELEASE FOR THE HEARTRESCUE CHINA PROGRAMBy Nasdaq OMXApr 20, 2018, 1:20 PM UTC
BusinessColibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility StudyBy Nasdaq OMXMar 19, 2018, 2:52 PM UTC
BusinessKarmanos Cancer Institute and Wayne State University conduct Community-Engaged Research symposium Feb. 5By Nasdaq OMXJan 11, 2018, 6:47 PM UTC
BusinessStreetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’By Nasdaq OMXDec 7, 2017, 1:45 PM UTC
